ANI shareholders approve doubling authorized common shares to 66M and equity plan amendments

ANI PHARMACEUTICALS INC

Stockholders approved Certificate of Amendment raising authorized common shares from 33,333,334 to 66,000,000; effective May 22, 2025.
Amended 2022 Stock Incentive Plan approved (15,056,885 for, 1,202,893 against, 10,460 abstain).
Amended 2016 Employee Stock Purchase Plan approved (16,173,976 for, 89,098 against, 7,164 abstain).
Eight director nominees elected; EisnerAmper LLP ratified as auditor; say-on-pay advisory approved.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

ANI PHARMACEUTICALS INC: Amended Restated Certificate of Incorporation to increase authorized common stock from 33,333,334 to 66,000,000 shares (effective 2025-05-22).

Change: charter amendment
Effective: 2025-05-22

Exact text from the filing

the amendment to the Company’s Restated Certificate of Incorporation (the “Certificate of Amendment”), providing for an increase to the number of authorized shares of common stock from 33,333,334 shares to 66,000,000 shares

View on SEC.gov

Browse all governance changes →

ANI PHARMACEUTICALS INC filing history →

Source: SEC EDGAR

accession 0001023024-25-000056

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.